Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors : a study of the German Testicular Cancer Study GroupBOKEMEYER, C; OECHSLE, K; HONECKER, F et al.Annals of oncology. 2008, Vol 19, Num 3, pp 448-453, issn 0923-7534, 6 p.Article

A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumorsTHEODORE, C; CHEVREAU, C; YATAQHENE, Y et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1465-1469, issn 0923-7534, 5 p.Article

Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxelMECCA, Caterina; PONZETTI, Agostino; CALIENDO, Virginia et al.EJD. European journal of dermatology. 2012, Vol 22, Num 6, pp 758-761, issn 1167-1122, 4 p.Article

Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumorsOECHSLE, Karin; BOKEMEYER, Carsten; HONECKER, Friedemann et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 1, pp 165-167, issn 0171-5216, 3 p.Article

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II studyPECTASIDES, D; PECTASIDES, M; FARMAKIS, D et al.Annals of oncology. 2004, Vol 15, Num 3, pp 493-497, issn 0923-7534, 5 p.Article

Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin- refractory nonseminomatous germ cell tumor. CommentaryDE GIORGI, Ugo; ROSTI, Giovanni; BEUZEBOC, Philippe et al.European urology. 2006, Vol 50, Num 5, pp 1032-1039, issn 0302-2838, 8 p.Article

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell TumorsOECHSLE, Karin; KOLLMANNSBERGER, Christian; HONECKER, Friedemann et al.European urology. 2011, Vol 60, Num 4, pp 850-855, issn 0302-2838, 6 p.Article

Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic featuresDE GIORGI, Ugo; ROSTI, Giovanni; SALVIONI, Roberto et al.Urologic oncology. 2011, Vol 29, Num 3, pp 284-290, issn 1078-1439, 7 p.Article

Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: A phase II studyPECTASIDES, Dimitrios; PECTASIDES, Melina; RAPTIS, Sotirios A et al.European urology. 2004, Vol 46, Num 2, pp 216-221, issn 0302-2838, 6 p.Article